Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2002 Nov;89(5):711-4.

Efficacy of intravenous magnesium in neuropathic pain

S Brill  1 , P M Sedgwick, W Hamann, P P Di Vadi
Affiliations
  • PMID: 12393768
Free article
Clinical Trial

Efficacy of intravenous magnesium in neuropathic pain

S Brill et al. Br J Anaesth. 2002 Nov.
Free article

Abstract

Background: Postherpetic neuralgia is a complication of acute herpes zoster characterized by severe pain and paraesthesia in the skin area affected by the initial infection. There is evidence that the N-methyl-D-aspartate receptor is involved in the development of hypersensitivity states and it is known that magnesium blocks the N-methyl-D-aspartate receptor.

Method: A double-blind, placebo-controlled, cross-over study was conducted in which magnesium sulphate was administered as an i.v. infusion. Spontaneous pain was recorded and qualitative sensory testing with cotton wool was performed in seven patients with postherpetic neuralgia before and after the i.v. administration of either magnesium sulphate 30 mg kg(-1) or saline.

Results: During the administration, pain scores were significantly lower for magnesium compared with placebo at 20 and 30 min (P=0.016) but not at 10 min. I.V. magnesium sulphate was safe, well-tolerated and effective in patients with postherpetic neuralgia.

Conclusion: The present study supports the concept that the N-methyl-D-aspartate receptor is involved in the control of postherpetic neuralgia.

PubMed Disclaimer

Comment in

Publication types